Quest Diagnostics Inc.’s DGX robust Advanced Diagnostics offering is poised to drive its growth in the upcoming quarters. Strength in the company’s core business is highly encouraging. Additionally, a ...
On Friday, Quest Diagnostics Inc (DGX) stock saw a modest uptick, ending the day at $160.44 which represents a slight increase of $3.60 or 2.30% from the prior close of $156.84. The stock opened at ...
Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.